Orchestra BioMed Holdings (OBIO) EBT Margin (QoQ) (2022 - 2026)

Orchestra BioMed Holdings (OBIO) EBT Margin (QoQ) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Orchestra BioMed Holdings 265.06 Mn 80.63 Mn 63,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -623,636.00
Mar 31, 2026 -2.25 Mn
Dec 31, 2025 240,604.00
Sep 30, 2025 19,454.00
Jun 30, 2025 -34,684.00
Mar 31, 2025 412,978.00
Dec 31, 2024 -457,744.00
Sep 30, 2024 145,212.00
Jun 30, 2024 -68,947.00
Mar 31, 2024 221,568.00
Dec 31, 2023 49,139.00
Sep 30, 2023 -340,180.00
Jun 30, 2023 -83,134.00
Mar 31, 2023 -10,740.00
Dec 31, 2022 -1,571.00
Sep 30, 2022 106,895.00
Jun 30, 2022 -134,843.00